---
title: "据彭博新闻报道，诺和诺德公司为了削减成本，已停止糖尿病细胞疗法的研究工作"
description: "诺和诺德公司已削减其细胞治疗部门，该部门一直在努力寻找 1 型糖尿病的治疗方法，彭博新闻周五援引一份声明报道"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/260667796.md"
published_at: "2025-10-10T15:52:08.000Z"
---

# 据彭博新闻报道，诺和诺德公司为了削减成本，已停止糖尿病细胞疗法的研究工作

> 诺和诺德公司已削减其细胞治疗部门，该部门一直在努力寻找 1 型糖尿病的治疗方法，彭博新闻周五援引一份声明报道

彭博新闻周五报道称，诺和诺德公司已削减其细胞治疗部门，该部门一直在努力寻找 1 型糖尿病的治疗方法，引用了一份声明。

### Related Stocks

- [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo set to make Wegovy pill in Ireland for markets outside US - Bloomberg News | Novo set to make Wegovy pill in Ireland for markets outside US - Bloomberg News | [Link](https://longbridge.com/zh-CN/news/275772102.md) |
| Novo Nordisk Aims To Start Selling Its Weight-Loss Blockbuster Wegovy In Vials - Bloomberg News | NOVO NORDISK AIMS TO START SELLING ITS WEIGHT-LOSS BLOCKBUSTER WEGOVY IN VIALS - BLOOMBERG NEWS | [Link](https://longbridge.com/zh-CN/news/275654518.md) |
| Assessing Novo Nordisk (CPSE:NOVO B) Valuation After Recent Share Price Pullback And Mixed Returns | Novo Nordisk (CPSE:NOVO B) has experienced mixed returns, with a recent 1.7% gain but a 17.6% decline over the past mont | [Link](https://longbridge.com/zh-CN/news/275941659.md) |
| Activist Third Point Builds Indra Stake, Urges Board To Buy Em&E - Bloomberg News | ACTIVIST THIRD POINT BUILDS INDRA STAKE, URGES BOARD TO BUY EM&E - BLOOMBERG NEWS | [Link](https://longbridge.com/zh-CN/news/276068592.md) |
| BRIEF-Digital Bank Maya Is Said To Weigh US IPO Of Up To $1 Billion - Bloomberg News | Feb 16 (Reuters) - * DIGITAL BANK MAYA IS SAID TO WEIGH US IPO OF UP TO $1 BILLION - BLOOMBERG NEWS Source text: Further | [Link](https://longbridge.com/zh-CN/news/276039136.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。